In contrast to the positive effect by HLA-neoantigen dependent immune stimulation, the release of IFNs from the activated T cells promotes the expression of PD-L1 in tumor environment (Garcia-Diaz et al., 2017). The gene discussed is CD274; the disease is neoplasm.